SEP 16, 2021 4:00 AM PDT

Trapped! An Immune Cell Tag Team Takes Down Bacteria.

WRITTEN BY: Tara Fernandez

Spiders are among nature’s most sophisticated hunters. Many build intricate webs out of silk and lie in wait for an unsuspecting victim to get trapped in the sticky fibers. Then, they lunge forward, biting and paralyzing their prey which quickly becomes their next meal.

Interestingly, our immune cells adopt a similar approach when it comes to making bacteria their prey. “Neutrophils produce the spider webs that immobilize the bacteria, and macrophages are the spiders that engulf and kill the bacteria,” explained microbiologist, Eric Skaar from the Vanderbilt Institute for Infection, Immunology, and Inflammation.

Skaar and colleagues recently identified a novel mechanism through which different immune cells work together to destroy and eliminate invading pathogens such as Staphylococcus aureus (staph). Initially, much of the responsibility to keep microbes at bay was thought to lie on neutrophils, agile and dynamic white blood cells, which rapidly show up at the site of infections before launching an all-out war on pathogens.

Neutrophils are known to produce neutrophil extracellular traps (NETs), threads of neutrophil DNA that act much like spiderwebs, trapping microbial prey among their sticky fibers laced with antimicrobial peptides. Interestingly, the researchers found that NETs did not make isolated neutrophils better at killing bacteria.

Instead, NETs enhanced the activity of macrophages, stimulating these phagocytic cells to gobble up trapped bacteria, thereby more efficiently clearing the site of infection.

“The macrophages end up with not only their own antibacterial arsenal but also the neutrophils’ antibacterial arsenal, all in the same compartment killing the bacteria,” Skaar said. This distinct cooperative immune defense mechanism was found to be the immune system’s go-to approach for defeating bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa.

These findings lay the groundwork for more avenues of exploration, including how genetic variations in neutrophils impact infection susceptibilities.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
AUG 27, 2021
Health & Medicine
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
AUG 27, 2021
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
Since their discovery, there has been an interest in how ABO blood groups and infectious diseases may be related. In add ...
SEP 06, 2021
Microbiology
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
SEP 06, 2021
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
HIV vaccines have remained elusive in part because the virus has a powerful ability to mutate, and there are so many str ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
OCT 04, 2021
Health & Medicine
Guillain-Barre Syndrome After COVID-19 Infection
OCT 04, 2021
Guillain-Barre Syndrome After COVID-19 Infection
Researchers with the International GBS Outcome Study (IGOS) investigated newly-diagnosed GBS patients from the beginning ...
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
Loading Comments...